1. Home
  2. TLSA vs LODE Comparison

TLSA vs LODE Comparison

Compare TLSA & LODE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSA
  • LODE
  • Stock Information
  • Founded
  • TLSA 2013
  • LODE 2008
  • Country
  • TLSA United Kingdom
  • LODE United States
  • Employees
  • TLSA N/A
  • LODE N/A
  • Industry
  • TLSA Biotechnology: Pharmaceutical Preparations
  • LODE Major Chemicals
  • Sector
  • TLSA Health Care
  • LODE Industrials
  • Exchange
  • TLSA Nasdaq
  • LODE Nasdaq
  • Market Cap
  • TLSA 87.8M
  • LODE 79.6M
  • IPO Year
  • TLSA 2000
  • LODE N/A
  • Fundamental
  • Price
  • TLSA $0.79
  • LODE $0.35
  • Analyst Decision
  • TLSA
  • LODE Buy
  • Analyst Count
  • TLSA 0
  • LODE 1
  • Target Price
  • TLSA N/A
  • LODE $2.60
  • AVG Volume (30 Days)
  • TLSA 1.1M
  • LODE 6.6M
  • Earning Date
  • TLSA 02-25-2025
  • LODE 02-26-2025
  • Dividend Yield
  • TLSA N/A
  • LODE N/A
  • EPS Growth
  • TLSA N/A
  • LODE N/A
  • EPS
  • TLSA N/A
  • LODE N/A
  • Revenue
  • TLSA N/A
  • LODE $1,864,811.00
  • Revenue This Year
  • TLSA N/A
  • LODE $69.41
  • Revenue Next Year
  • TLSA N/A
  • LODE $56.83
  • P/E Ratio
  • TLSA N/A
  • LODE N/A
  • Revenue Growth
  • TLSA N/A
  • LODE 117.46
  • 52 Week Low
  • TLSA $0.41
  • LODE $0.13
  • 52 Week High
  • TLSA $1.74
  • LODE $1.01
  • Technical
  • Relative Strength Index (RSI)
  • TLSA 56.56
  • LODE 43.59
  • Support Level
  • TLSA $0.65
  • LODE $0.35
  • Resistance Level
  • TLSA $0.70
  • LODE $0.41
  • Average True Range (ATR)
  • TLSA 0.05
  • LODE 0.03
  • MACD
  • TLSA 0.01
  • LODE 0.00
  • Stochastic Oscillator
  • TLSA 100.00
  • LODE 23.89

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

About LODE Comstock Inc.

Comstock Inc is engaged in technologies that efficiently use wasted and under-utilized natural resources to produce renewable energy and other products that contribute to balancing uses and emissions of carbon and enhance mineral and material discoveries. The segments of the company are Fuels Metals, Mining, Strategic Investments, and Corporate. The company derives maximum revenue from Strategic Investments segment. The Strategic Investments Segment includes minority equity investments in Quantum Generative Materials LLC (physics-based artificial intelligence), Green Li-ion Pte Limited (lithium-ion battery recycling and cathode production), Sierra Springs Opportunity Fund (strategic direct investment in northern Nevada real estate), and other equity or equity-linked investments.

Share on Social Networks: